CURI vs GTN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

CURI

45.9
AI Score
VS
CURI Wins

GTN

43.9
AI Score

Investment Advisor Scores

CURI

46score
Recommendation
HOLD

GTN

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CURI GTN Winner
Forward P/E 8.1766 2.3804 GTN
PEG Ratio 0 0.1134 Tie
Revenue Growth 22.3% 8.7% CURI
Earnings Growth 1400.0% 1016.4% CURI
Tradestie Score 45.9/100 43.9/100 CURI
Profit Margin 0.0% -0.8% CURI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CURI 1M: -13.9% · 3M: -13.9% GTN 1M: +31.4% · 3M: +20.2%

Current Technical Phase

CURI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 35

RSI (14): 35.2 · Price: $2.41

GTN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 77

RSI (14): 76.9 · Price: $5.82

Fundamentals Snapshot

Metric CURI GTN
Market Cap — —
Forward P/E 7.8 -8.3
Trailing P/E — 17.5
Revenue (TTM) — —
Revenue Growth 0.2% 0.3%
Gross Margin 0.6% 0.3%
Operating Margin 0.4% 0.3%
EPS 0.00 0.32
Dividend Yield 0.13% 0.07%

Frequently Asked Questions

Based on our detailed analysis, CURI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.